Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource

Dendrou, Calliope A, Plagnol, Vincent, Fung, Erik, Yang, Jennie H M, Downes, Kate, Cooper, Jason D, Nutland, Sarah, Coleman, Gillian, Himsworth, Matthew, Hardy, Matthew, Burren, Oliver, Healy, Barry, Walker, Neil M, Koch, Kerstin, Ouwehand, Willem H, Bradley, John R, Wareham, Nicholas J, Todd, John A, Wicker, Linda S·2009·Nature Genetics
DOI 10.1038/ng.434

Cited by (281)

Items 101–200 of 281

  1. Restoring Regulatory T Cells in Type 1 Diabetes
    Allyson L. Spence, Qizhi Tang · 2016 · Current Diabetes Reports
  2. Generation of primary human intestinal T cell transcriptomes reveals differential expression at genetic risk loci for immune-mediated disease
    Tim Raine, Jimmy Z. Liu, Carl A. Anderson, Miles Parkes, Arthur Kaser · 2014 · Gut
  3. Beyond Regulatory T Cells: The Potential Role for IL-2 to Deplete T-Follicular Helper Cells and Treat Autoimmune Diseases
    André Ballesteros‐Tato · 2014 · Immunotherapy
  4. Genetics in PSC: What Do the “Risk Genes” Teach Us?
    Trine Folseraas, Evaggelia Liaskou, Carl A. Anderson, Tom H. Karlsen · 2014 · Clinical Reviews in Allergy & Immunology
  5. Multiple sclerosis associated genetic variants ofCD226impair regulatory T cell function
    Melanie Piédavent, Anne Willing, Jan Broder Engler, Karin Steinbach, Simone Bauer, Britta Eggert, Friederike Ufer, Nina Kursawe, Sabine Wehrmann, Jan Jäger et al. · 2015 · Brain
  6. Blood pressure and human genetic variation in the general population
    Pankaj Kumar Arora, Christopher Newton‐Cheh · 2010 · Current Opinion in Cardiology
  7. Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity
    Benjamin F. Voight, Chris J. Cotsapas · 2012 · Current Opinion in Immunology
  8. Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial
    Frank Waldron-Lynch, Paula Kareclas, Irons Kathryn, Neil M Walker, Adrian Mander, Linda S. Wicker, John A Todd, Simon James Bond · 2014 · BMJ Open
  9. Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis
    Maria E. Joosse, Fabienne Charbit‐Henrion, Remy Boisgard, Rolien C. Raatgeep, Dicky J. Lindenbergh-Kortleve, Lea M. M. Costes, Sandrine Nugteren, Nicolas Guégan, Marianna Parlato, Sharon Veenbergen et al. · 2021 · Mucosal Immunology
  10. Evidence that Cd101 Is an Autoimmune Diabetes Gene in Nonobese Diabetic Mice
    Daniel B. Rainbow, Carolyn L. Moule, Heather I. Fraser, Jan Clark, Sarah Howlett, Oliver S. Burren, Mikkel B. Christensen, Val Moody, Charles A. Steward, Javid P. Mohammed et al. · 2011 · The Journal of Immunology
  11. Risk conferring genes in multiple sclerosis
    Sandra Nischwitz, Bertram Müller‐Myhsok, Frank Weber · 2011 · FEBS Letters
  12. Genome-wide association studies of hematologic phenotypes: a window into human hematopoiesis
    Vijay G. Sankaran, Stuart H. Orkin · 2013 · Current Opinion in Genetics & Development
  13. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion
    Ezio E. Bonifacio, Jan Krumsiek, Christiane Winkler, Fabian Joachim Theis, Anette‐Gabriele Ziegler · 2013 · Acta Diabetologica
  14. Mechanistic Basis of Immunotherapies for Type 1 Diabetes Mellitus
    Wen-Hao Chen, A. Xie, L. Chan · 2013 · Translational Research: The Journal of Laboratory and Clinical Medicine
  15. Unravelling the Roles of Susceptibility Loci for Autoimmune Diseases in the Post-GWAS Era
    Yi Ye, Kathleen M. Gillespie, Santiago Rodrı́guez · 2018 · Genes
  16. IL ‐2 promotes the function of memory‐like autoregulatory CD 8+ T cells but suppresses their development via F ox P 3+ T reg cells
    Afshin Shameli, Jun Yamanouchi, Sue Jean Tsai, Yang Yang, Xavier Clemente‐Casares, Anna V. Moore, Pau Serra, Pere Santamaría · 2012 · European Journal of Immunology
  17. IL2RA is associated with persistence of rheumatoid arthritis
    Hanna W. van Steenbergen, Jessica A B van Nies, Adeline Ruyssen‐Witrand, Tom W. J. Huizinga, A. Cantagrel, Françis Berenbaum, Annette H M van der Helm–van Mil · 2015 · Arthritis Research & Therapy
  18. A pilot study showing associations between frequency of CD4+ memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes
    Rosita Moya, Hannah Kathryn Robertson, Dawson Payne, Aditi A. Narsale, Jim Koziol, Joanna Davida Davies · 2016 · Clinical Immunology
  19. Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry
    Erik Fung, Laura Esposito, John A. Todd, Linda S. Wicker · 2010 · Nature Protocols
  20. Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects
    Matthew W. Klinker, Jennifer J. Schiller, Victoria L. Magnuson, Tao Wang, Joel Basken, Kerry N. Veth, Kaela I. Pearce, Leena Kinnunen, Valma Harjutsalo, Xujing Wang et al. · 2009 · Immunogenetics
  21. Genetics Coming of Age in Type 1 Diabetes
    Karen Cerolsaletti, Wei Hao, Carla J. Greenbaum · 2019 · Diabetes Care
  22. IL2RA Gene Polymorphism rs2104286 A>G Seen in Multiple Sclerosis Is Associated with Intermediate Uveitis: Possible Parallel Pathways?
    Ewald Lindner, Martin Weger, Gernot Steinwender, Antonia Griesbacher, Ursula Posch, Silvia Ulrich, Beate Julia Wegscheider, Navid Ardjomand, Yosuf El‐Shabrawi · 2011 · Investigative Ophthalmology & Visual Science
  23. Genetics in primary sclerosing cholangitis
    Trine Folseraas, Espen Melum, André Franke, Tom H. Karlsen · 2011 · Best Practice & Research Clinical Gastroenterology
  24. Genetic Mechanisms Highlight Shared Pathways for the Pathogenesis of Polygenic Type 1 Diabetes and Monogenic Autoimmune Diabetes
    Matthew B. Johnson, K. Cerosaletti, S. Flanagan, J. Buckner · 2019 · Current Diabetes Reports
  25. Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial
    Maria Loredana Marcovecchio, Linda S. Wicker, David B. Dunger, Susan Dutton, Sylwia Kopijasz, Claire L. Scudder, John A. Todd, Paul R V Johnson · 2020 · Wellcome Open Research
  26. The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease
    Javier Ochoa‐Repáraz, Lloyd H. Kasper · 2016 · Translational research
  27. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives
    Nicole Beatriz Lopes Damascena Costa, Oriana Marques, Sandra Íris Sanches Godinho, Cláudia Carvalho, Bárbara Leal, Ana M. Figueiredo, Carlos Vasconcelos, António Marinho, Maria Francisca Moraes‐Fontes, António Gomes da Costa et al. · 2017 · Clinical & Experimental Immunology
  28. Progress in Understanding Type 1 Diabetes Through Its Genetic Overlap with Other Autoimmune Diseases
    Jeffrey D. Roizen, Jonathan P. Bradfield, Hakon H. Hakonarson · 2015 · Current Diabetes Reports
  29. Stochastic search and joint fine-mapping increases accuracy and identifies previously unreported associations in immune-mediated diseases
    Jennifer L. Asimit, Daniel B. Rainbow, Mary D Fortune, Nastasiya F. Grinberg, Linda S. Wicker, Chris Wallace · 2019 · Nature Communications
  30. Tacrolimus Pharmacodynamics and Pharmacogenetics along the Calcineurin Pathway in Human Lymphocytes
    Ofelia Noceti, Jean‐Baptiste Woillard, A. Boumédiène, Patricia Esperón, Jean‐Luc Taupin, Solange Gerona, Marcelo Valverde, Cristina Touriño, Pierre Marquet · 2014 · Clinical Chemistry
  31. Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls
    Sophie Buhelt, Helle Bach Søndergaard, Annette Bang Oturai, Henrik Ullum, Marina Rode von Essen, Finn Thorup Sellebjerg · 2019 · Cells
  32. Susceptibility genes for rheumatoid arthritis - a rapidly expanding harvest.
    Peter K. Gregersen · 2010 · PubMed
  33. Pre-diagnostic genotyping identifies T1D subjects with impaired Treg IL-2 signaling and an elevated proportion of FOXP3+IL-17+ cells
    Ashish Marwaha, Constadina Panagiotopoulos, Catherine M. Biggs, S Staiger, Kate L. Del Bel, Aaron F. Hirschfeld, John J. Priatel, Stuart E. Turvey, Rusung Tan · 2017 · Genes and Immunity
  34. Genetic overlap between type 1 diabetes and other autoimmune diseases
    Ana Márquez, Javier J. Martin · 2021 · Seminars in Immunopathology
  35. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
    J-E Martin, F. David Carmona, Jasper C. A. Broen, Carmen Pilar Simeón‐Aznar, M C Vonk, Patricia Esmeralda Carreira, Raquel Ríos-Fernández, Gerard Espinosa, Esther F. Vicente‐Rabaneda, Carles Tolosa-Vilella et al. · 2011 · Genes and Immunity
  36. Association of common polymorphisms in the IL 2 RA gene with type 1 diabetes: evidence of 32,646 individuals from 10 independent studies
    Wei Tang, Dai Cui, Lin Jiang, Lijuan Zhao, Wei Qian, Sarah Alice Long, Kuanfeng Xu · 2015 · Journal of Cellular and Molecular Medicine
  37. Interleukin 2 receptor α chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern Japanese
    Gulibahaer Ainiding, Yuji Kawano, Shinya Sato, Noriko Isobe, Takuya Matsushita, Satoshi Yoshimura, Tomomi Yonekawa, Ryo Yamasaki, Hiroyuki Murai, Jun‐ichi Kira · 2013 · Journal of the Neurological Sciences
  38. Progress in Multiple Sclerosis Genetics
    An Goris, Ine Pauwels, Bénédicte Dubois · 2012 · Current Genomics
  39. Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers
    Vera Pravica, Dusan M. Popadic, Emina Savić, Miloš Marković, Jelena S. Drulovic, Marija Mostarica‐Stojković · 2012 · Immunologic Research
  40. Effects of genetic variation in the P2RX7 gene on pharmacodynamics of a P2X7 receptor antagonist: a prospective genotyping approach
    Simon M. McHugh, Shilina A. Roman, Bill G Davis, Annelize Koch, Alison M. Pickett, Jill C. Richardson, Sam R. Miller, Sally Wetten, Charles J. Cox, Fredrik Karpe et al. · 2012 · British Journal of Clinical Pharmacology
  41. Dense Genotyping of Immune-Related Regions Identifies Loci for Rheumatoid Arthritis Risk and Damage in African Americans
    Maria I. Danila, Vincent A. Laufer, Richard J. Reynolds, Qi Yan, Nianjun Liu, Peter K. Gregersen, Annette Lee, Marlena Kern, Carl D. Langefeld, Donna K. Arnett et al. · 2017 · Molecular Medicine
  42. Study of Transcriptional Effects in Cis at the IFIH1 Locus
    H. Zouk, L. Marchand, C. Polychronakos · 2010 · PLoS ONE
  43. Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
    Lucy A. Truman, Marcin Ł. Pękalski, Paula Kareclas, Marina Evangelou, Neil M Walker, James Howlett, Adrian Mander, Jane Kennet, Linda S. Wicker, Simon James Bond et al. · 2015 · BMJ Open
  44. Closing the gap between genotype and phenotype
    Peter K. Gregersen · 2009 · Nature Genetics
  45. Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis
    Marie‐Claude Babron, Hervé Perdry, Adam E. Handel, Sreeram V. Ramagopalan, Vincent Damotte, Bertrand Fontaine, Bertram Müller‐Myhsok, George C. Ebers, Françoise Clerget‐Darpoux · 2011 · European Journal of Human Genetics
  46. Transcriptomes of antigen presenting cells in human thymus
    Gabrielsen, Ingvild S. M., Helgeland, Hanna, Akselsen, Helle, D. Aass, Hans Christian, Sundaram, Arvind Y. M., Snowhite, Isaac V., Pugliese, Alberto, Flåm, Siri T., Lie, Benedicte A. · 2019 · PLOS ONE
  47. Renegade homeostatic cytokine responses in T1D: Drivers of regulatory/effector T cell imbalance
    Shipra Sen Gupta, Karen M. Cerosaletti, Sarah Alice Long · 2014 · Clinical Immunology
  48. GWAS implicates a role for quantitative immune traits and threshold effects in risk for human autoimmune disorders
    Peter K. Gregersen, Betty Diamond, Robert M. Plenge · 2012 · Current Opinion in Immunology
  49. Genetics in primary sclerosing cholangitis
    Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, André Franke, Tom H. Karlsen · 2012 · Clinics and Research in Hepatology and Gastroenterology
  50. SigniSite: Identification of residue-level genotype-phenotype correlations in protein multiple sequence alignments
    Leon Eyrich Jessen, Ilka Hoof, Ole Lund, Morten Nielsen · 2013 · Nucleic Acids Research
  51. Chromosome contacts in activated T cells identify autoimmune disease candidate genes
    Oliver S. Burren, Arcadio Rubio García, Biola M. Javierre, Daniel B. Rainbow, Jonathan Cairns, Nicholas J Cooper, John J. Lambourne, Ellen C. Schofield, Xaquín Castro Dopico, Ricardo C. Ferreira et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Identifying genetic variants that influence the abundance of cell states in single-cell data
    Laurie Rumker, Saori Sakaue, Yakir Reshef, Joyce B. Kang, Seyhan Yazar, José Alquicira-Hernández, Cristian Valencia, Kaitlyn A. Lagattuta, Annelise Y. Mah-Som, Aparna Nathan et al. · 2024 · Nature Genetics
  53. Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes
    Mark A. Wallet, Katherine E. Santostefano, Naohiro Terada, Todd M. Brusko · 2017 · Frontiers in Endocrinology
  54. IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis
    Hannes Lindahl, André Ortlieb Guerreiro‐Cacais, Sahl Khalid Bedri, Mathias Linnerbauer, Magdalena Lindén, Nada Abdelmagid, Karolina Tandre, Lauren Claire Hollins, Lorraine M. Irving, Colin P. J. Glover et al. · 2019 · The Journal of Immunology
  55. Genetics and Epigenetics of the Skin Meet Deep Sequence
    Jeffrey B. Cheng, Raymond Jaihyun Cho · 2012 · Journal of Investigative Dermatology
  56. Fluorescence Intensity Normalisation: Correcting for Time Effects in Large-Scale Flow Cytometric Analysis
    Calliope Athena Dendrou, Erik Fung, Laura Esposito, John A. Todd, Linda S. Wicker, Vincent Plagnol · 2009 · Advances in Bioinformatics
  57. Myelin matters: proteomic insights into white matter disorders
    Hauke B. Werner, Olaf Jahn · 2010 · Expert Review of Proteomics
  58. TNF Production in Macrophages Is Genetically Determined and Regulates Inflammatory Disease in Rats
    Alan Gillett, Mónica Marta, Tao Jin, Jonatan Tuncel, Patrick Leclerc, Rita Georges Nohra, Stefan Lange, Rikard Holmdahl, Tomas P Olsson, Robert Adam Harris et al. · 2010 · The Journal of Immunology
  59. IL-2 as a therapeutic target for the restoration of Foxp3+ regulatory T cell function in organ-specific autoimmunity: implications in pathophysiology and translation to human disease
    Eva B. d'Hennezel, Mara Kornete, Ciriaco A. Piccirillo · 2010 · Journal of Translational Medicine
  60. Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis
    Sophie Buhelt, Rikke Lenhard Ratzer, Jeppe Romme Christensen, Lars Svend Börnsen, Finn Thorup Sellebjerg, Helle Bach Søndergaard · 2017 · Cytokine
  61. A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis
    Stephanie Maiwald, M. Mahdi Motazacker, Julian C. van Capelleveen, Suthesh Sivapalaratnam, Allard C. van der Wal, Chris M. van der Loos, John J.P. Kastelein, Willem Hendrik Ouwehand, G. Kees Hovingh, Mieke D. Trip et al. · 2015 · European Journal of Human Genetics
  62. Enhanced genetic analysis of type 1 diabetes by selecting variants on both effect size and significance, and by integration with autoimmune thyroid disease
    Daniel J. M. Crouch, J. Inshaw, Catherine C. Robertson, Jia-Yuan Zhang, Wei-Min Chen, S. Onengut-Gumuscu, Antony J. Cutler, C. Sidore, F. Cucca, F. Pociot et al. · 2021 · bioRxiv
  63. Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes
    Yang, Jennie H. M., Ward‐Hartstonge, Kirsten A., Perry, Daniel J., Blanchfield, J. Lori, Posgai, Amanda L., Wiedeman, Alice E., Diggins, Kirsten, Rahman, Adeeb, Tree, Timothy I. M., Brusko, Todd M. et al. · 2022 · European Journal of Immunology
  64. Study of polymorphisms in 4q27, 10p15, and 22q13 regions in autoantibodies stratified type 1 diabetes patients
    Laura Espino‐Paisán, Hermenegildo de la Calle, Miguel Fernández‐Arquero, M. Angeles Figueredo, Emilio G. de la Concha, Elena Urcelay, José Luis Santiago · 2011 · Autoimmunity
  65. From Markers to Molecular Mechanisms: Type 1 Diabetes in the Post-GWAS Era
    Alan G. Baxter, Margaret A. Jordan · 2012 · The Review of Diabetic Studies
  66. ZFAT plays critical roles in peripheral T cell homeostasis and its T cell receptor-mediated response
    Keiko Doi, Takahiro Fujimoto, Tadashi Okamura, Masahiro Ogawa, Yôko Tanaka, Yasumasa Mototani, Motohito Goto, Takeharu Ota, Hiroshi Matsuzaki, Masahide Kuroki et al. · 2012 · Biochemical and Biophysical Research Communications
  67. Type 1 Diabetes Genetics Consortium
    Suna Önengüt-Gümüşcü, PATRICK J. CONCANNON, Beena Akolkar, Henry A Erlich, Cécile Julier, Grant Morahan, Concepcion R. Nierras, Flemming Pociot, John A. Todd, Stephen S. Rich · 2025 · The Journal of Clinical Endocrinology & Metabolism
  68. IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells
    Sophie Buhelt, Hannah-Marie Laigaard, Marina Rode von Essen, Henrik Ullum, Annette Bang Oturai, Finn Thorup Sellebjerg, Helle Bach Søndergaard · 2021 · Frontiers in Immunology
  69. Clinical Applications of Regulatory T cells in Adoptive Cell Therapies
    Gregory P. Marshall, Judit Cserny, Daniel J. Perry, Wen-I Yeh, Howard R. Seay, Ahmed G Elsayed, Amanda L. Posgai, Todd M. Brusko · 2018 · Cell and Gene Therapy Insights
  70. Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2
    Gehan Ahmed Mostafa, Hanan Mohamed Ibrahim, Abeer Al Sayed Shehab, Yasmin G. El Gendy, Dina Medhat Mohamed Aly, Ghada Abdel Haleem Shousha · 2022 · European Journal of Pediatrics
  71. Pro-inflammatory cytokines in cystic glioblastoma: A quantitative study with a comparison with bacterial brain abscesses. With an MRI investigation of displacement and destruction of the brain tissue surrounding a glioblastoma
    Bjørnar Hassel, Pitt Niehusmann, Bente Lise Halvorsen, Daniel Dahlberg · 2022 · Frontiers in Oncology
  72. The Genotype and Phenotype (GaP) registry: a living biobank for the analysis of quantitative traits
    Peter K. Gregersen, Gila Klein, Mary Keogh, Marlena Kern, Margaret DeFranco, Kim R. Simpfendorfer, Sun Jung Kim, Betty Diamond · 2015 · Immunologic Research
  73. Polymorphic variants of the IL2RA gene and susceptibility to type 1 diabetes in the Polish population
    Marta Fichna, Magdalena Żurawek, Piotr Fichna, Danuta Januszkiewicz, Jerzy Nowak · 2011 · Tissue Antigens
  74. Lipophagic Panniculitis of Childhood: A Case Report and Comprehensive Review of the Literature
    Jack Levy, Mark E. Burnett, CYNTHIA M.J. MAGRO · 2017 · American Journal of Dermatopathology
  75. Coordinating GWAS results with gene expression in a systems immunologic paradigm in autoimmunity
    Barbara E. Stranger, Philip L. De Jager · 2012 · Current Opinion in Immunology
  76. Identifying genetic loci and spleen gene coexpression networks underlying immunophenotypes in BXD recombinant inbred mice
    Rachel Lynch, Sudhir Naswa, Gary L. Rogers, Stephen A. Kania, Suchita Das, Elissa J. Chesler, Arnold M. Saxton, Michael Allen Langston, Brynn H. Voy · 2010 · Physiological Genomics
  77. Polymorphisms and haplotypes of IL2RA , IL10 , IFN G , IRF5, and CCR2 are associated with Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in children
    Nannan Tang, Junbin Huang, Chun Chen, Xiaojun Wu, Hong‐Gui Xu, Guohua Chen, Hongman Xue · 2021 · Pediatric Blood & Cancer
  78. Redefining disease
    John I. Bell · 2010 · Clinical Medicine
  79. Leveraging Human Genetics to Develop Future Therapeutic Strategies in Rheumatoid Arthritis
    Robert M. Plenge, Soumya Raychaudhuri · 2010 · Rheumatic Disease Clinics of North America
  80. The single nucleotide variant rs12722489 determines differential estrogen receptor binding and enhancer properties of an IL2RA intronic region
    Marina A. Afanasyeva, Lidia V. Putlyaeva, Д. Э. Демин, Ivan V. Kulakovskiy, Ilya E. Vorontsov, Marina V. Fridman, Vsevolod J. Makeev, Dmitry V. Kuprash, A. M. Schwartz · 2017 · PLoS ONE
  81. Transmission disequilibrium analysis of 31 type 1 diabetes susceptibility loci in Finnish families
    A. P. Laine, Mikael Knip, Jorma Ilonen, The Finnish Pediatric Diabetes Register · 2013 · Tissue Antigens
  82. A functional framework for interpretation of genetic associations in T1D
    Gerald T. Nepom, Jane Hoyt Buckner · 2012 · Current Opinion in Immunology
  83. Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)
    James J. N. Heywood, Marina Evangelou, Goymer Donna, Jane Kennet, Anselmiova Katerina, Catherine Guy, Criona O’Brien, Sarah L. Nutland, Brown Judy, Neil M Walker et al. · 2015 · Trials
  84. Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
    STANLEY L. COHAN · 2016 · Biologics
  85. Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation state
    Katharine V. Schwedhelm, Jerill Thorpe, Sara A. Murray, Marc A. Gavin, Cate Speake, Carla J. Greenbaum, Karen M. Cerosaletti, Jane Hoyt Buckner, Sarah Alice Long · 2017 · Clinical Immunology
  86. The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs’ activation and function
    Bogusław Nedoszytko, Małgorzata Sokołowska‐Wojdyło, Joanna Renke, Magdalena Lange, Piotr Trzonkowski, Michał Sobjanek, Aneta Szczerkowska‐Dobosz, Marek Niedoszytko, Aleksandra Górska, Jan Romantowski et al. · 2017 · Advances in Dermatology and Allergology
  87. Associations of Independent IL2RA Gene Variants with Intermediate Uveitis
    Ewald Lindner, Martin Weger, Navid Ardjomand, Wilfried Renner, Yosuf El‐Shabrawi · 2015 · PLoS ONE
  88. GWASs and the age of human as the model organism for autoimmune genetic research
    Robert M. Plenge · 2010 · Genome biology
  89. Intersection between genetic polymorphisms and immune deviation in type 1 diabetes
    Alice Long, Jane Hoyt Buckner · 2013 · Current Opinion in Endocrinology Diabetes and Obesity
  90. Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials
    Mukul Minocha, Jonathan Q. Tran, James P. Sheridan, Ahmed A. Othman · 2015 · Clinical Pharmacokinetics
  91. Pulmonary hemorrhage in a case of CD25 deficiency
    Nashat Al Sukaiti, Aisha Al Sinani, Suad Al-Ismaily, Samiuddin Shaikh, Safia Al-Abrawi · 2014 · LymphoSign Journal
  92. Cell type–specific eQTLs in the human immune system
    Peter K. Gregersen · 2012 · Nature Genetics
  93. FOXO in the Hole: Leveraging GWAS for Outcome and Function
    Peter K. Gregersen, Nataly Manjarrez‐Orduño · 2013 · Cell
  94. Genetics of Type 1 Diabetes
    M. Černá · 2011 · InTech eBooks
  95. IBD Genetics: Focus on (Dys) Regulation in Immune Cells and the Epithelium
    Arthur Kaser, Bogdan Paşaniuc · 2014 · Gastroenterology
  96. Immunotherapy in Type 1 Diabetes: A Shorter but More Winding Road?
    Ezio E. Bonifacio · 2012 · Diabetes
  97. Prognosis in autoimmune and infectious disease: new insights from genetics
    James Christopher Lee, Kenneth G. C. Smith · 2014 · Clinical & Translational Immunology
  98. Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes
    Luz Andreone, María Laura Gimeno, Marcelo Javier Perone · 2018 · Frontiers in Endocrinology
  99. Mutation in KERA Identified by Linkage Analysis and Targeted Resequencing in a Pedigree with Premature Atherosclerosis
    Stephanie Maiwald, Suthesh Sivapalaratnam, M. Mahdi Motazacker, Julian C. van Capelleveen, Ilze Bot, Saskia C.A. de Jager, Miranda Van Eck, Jennifer Jolley, Johan Kuiper, Jonathan C. Stephens et al. · 2014 · PLoS ONE
  100. Cellular Mechanisms of Restored β-Cell Tolerance Mediated by Protective Alleles of Idd3 and Idd5
    Emma E. Hamilton‐Williams, Jocelyn Cheung, Daniel B. Rainbow, Kara M. D. Hunter, Linda S. Wicker, Linda A. Sherman · 2011 · Diabetes